Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
- Twentyman E. Evidence to Recommendation Framework: Novavax COVID-19 Vaccine, Adjuvanted in adults ages 18 years and older. U.S. Advisory Committee on Immunization Practices meeting, July 19, 2022.
- CDC. Interim Clinical Considerations for Use of COVID-19 Vaccines Currently Approved or Authorized in the United States [Summary of recent changes (last updated July 20, 2022)].
Disclosure statements are available on the authors' profiles: